アジェンダ
9:00 AM — 9:10 AM
Welcome Remarks9:10 AM — 9:25 AM
Key Note 19:25 AM — 12:40 PM
Session 1: Edge of Small Molecule Development1:40 PM — 5:55 PM
Session 2: Strategy for Biosimilar Development & Approval5:55 PM — 6:05 PM
Wrap Up9:00 AM — 9:15 AM
Key Note 29:15 AM — 12:15 PM
Session 3: Check Points of Biologics Development1:15 PM — 5:15 PM
Session 4: Regulatory and Industry Perspectives in Clinical Development5:15 PM — 5:25 PM
Wrap Up5:25 PM — 5:30 PM
Closing Remarks